This workshop aims to clarify the ways to achieve regulatory acceptance of New Approach Methodologies (NAMs) by addressing the major obstacles to their implementation. It will showcase how innovation can be turned into practical application, emphasizing the key success factors for NAMs validation. Furthermore, the workshop seeks to bridge the gap between NAMs developers, end-users, and regulatory bodies, fostering a collaborative environment to streamline the adoption of these advanced methodologies.
Date: December 13th, 2024
Location: Bern, UniS, S003
Register by clicking here.
Accreditation for 1 day of continuing education (pending confirmation)
_____________________
Confirmed speakers:
State-of-the-art on technology: Dr Olivier Guenat, University of Bern
Regulatory status: Tatjana Petkovic / Elisabeth Klenke, Swissmedic
Case study 1: Dr Nathalie Brandenberg, DOPPL SA, & Dr Georgia Mitropoulou, CHUV
Case study 2: Dr Patrycja Nowak-Sliwinska, University of Geneva, & Dr Jeremy Mayer, HUG
State-of-the-art on technology: Dr Laura Suter-Dick, Fachhochschule Nordwestschweiz
Regulatory status: Tatjana Petkovic / Elisabeth Klenke, Swissmedic
Case study 1: Dr Francesco Nevelli & Morgane Rochemont, Merck
Case study 2: Dr Silvana Libertini, Novartis, & Dr Joana Ferreira, AstraZeneca